| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A collaborative approach to enabling stratified cancer medicine in the UK
|
Tuff-Lacey, Alice
|
|
2015
|
20 |
12 |
p. 1414-1418
5 p.
|
artikel
|
| 2 |
An introduction to stratified medicine
|
Greystoke, Alastair
|
|
2015
|
20 |
12 |
p. 1409-1413
5 p.
|
artikel
|
| 3 |
Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine
|
Thomas, David M.
|
|
2015
|
20 |
12 |
p. 1429-1432
4 p.
|
artikel
|
| 4 |
Clonotyping for precision oncology
|
Dang, Ha X.
|
|
2015
|
20 |
12 |
p. 1464-1469
6 p.
|
artikel
|
| 5 |
Contents page 2
|
|
|
2015
|
20 |
12 |
p. iii-
1 p.
|
artikel
|
| 6 |
Contents page 1
|
|
|
2015
|
20 |
12 |
p. i-
1 p.
|
artikel
|
| 7 |
Integrated molecular pathology: the Belfast model
|
Salto-Tellez, Manuel
|
|
2015
|
20 |
12 |
p. 1451-1454
4 p.
|
artikel
|
| 8 |
Next-generation sequencing and empowering personalised cancer medicine
|
McDermott, Ultan
|
|
2015
|
20 |
12 |
p. 1470-1475
6 p.
|
artikel
|
| 9 |
Norwegian Cancer Genomics Consortium: a platform for research on personalized cancer medicine in a public health system
|
Myklebost, Ola
|
|
2015
|
20 |
12 |
p. 1419-1421
3 p.
|
artikel
|
| 10 |
Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials
|
Hyman, David M.
|
|
2015
|
20 |
12 |
p. 1422-1428
7 p.
|
artikel
|
| 11 |
Precision medicine in oncology drug development: a pharma perspective
|
Hollingsworth, Simon J.
|
|
2015
|
20 |
12 |
p. 1455-1463
9 p.
|
artikel
|
| 12 |
The clinical benefits, ethics, and economics of stratified medicine and companion diagnostics
|
Trusheim, Mark R.
|
|
2015
|
20 |
12 |
p. 1439-1450
12 p.
|
artikel
|
| 13 |
The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform
|
Johnson, Amber
|
|
2015
|
20 |
12 |
p. 1433-1438
6 p.
|
artikel
|
Tijdschrift beschrijving